tiprankstipranks
Advertisement
Advertisement
AtriCure price target lowered to $53 from $64 at Canaccord
PremiumThe FlyAtriCure price target lowered to $53 from $64 at Canaccord
2M ago
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
Premium
Ratings
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
2M ago
Oppenheimer downgrades AtriCure on new competition from Edwards
Premium
The Fly
Oppenheimer downgrades AtriCure on new competition from Edwards
2M ago
AtriCure reports Q4 adjusted EPS 6c, consensus (11c)
PremiumThe FlyAtriCure reports Q4 adjusted EPS 6c, consensus (11c)
2M ago
ATRC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ATRC Earnings this Week: How Will it Perform?
2M ago
AtriCure: Sustained Growth and Market Leadership Expected Despite Emerging Competition
Premium
Ratings
AtriCure: Sustained Growth and Market Leadership Expected Despite Emerging Competition
2M ago
Outset Medical appoints Prange to its board of directors
PremiumThe FlyOutset Medical appoints Prange to its board of directors
3M ago
AtriCure Reports Strong Preliminary 2025 Revenue Growth
Premium
Company Announcements
AtriCure Reports Strong Preliminary 2025 Revenue Growth
3M ago
AtriCure price target raised to $48 from $42 at JPMorgan
Premium
The Fly
AtriCure price target raised to $48 from $42 at JPMorgan
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100